Elevated Plasma Fibrinogen Gamma' Concentration is Associated with Myocardial Infarction: Effects of Variation in Fibrinogen Genes and Environmental Factors
Overview
Authors
Affiliations
Background: Fibrinogen gamma', a fibrinogen gamma-chain variant generated via alternative mRNA processing, has been associated with susceptibility to thrombotic disease.
Objective: The present case-control study searched for potential determinants of the plasma fibrinogen gamma' concentration and examined the relationship between this variant and risk of myocardial infarction (MI).
Patients And Methods: The Stockholm Coronary Artery Risk Factor study, comprising 387 postinfarction patients and 387 healthy individuals, was employed. The fibrinogen gamma (FGG) 9340T > C [rs1049636], fibrinogen alpha (FGA) 2224G > A [rs2070011] and fibrinogen beta (FGB) 1038G > A [rs1800791] polymorphisms were determined. The plasma fibrinogen gamma' concentration was measured by enzyme-linked immunosorbent assay. The multifactor dimensionality reduction method was used for interaction analyses on risk of MI.
Results: The FGG 9340T > C and FGA 2224G > A polymorphisms, total plasma concentrations of fibrinogen, insulin and high-density lipoprotein, and gender appeared to be independent determinants of plasma fibrinogen gamma' concentration in patients, and the corresponding determinants in controls included FGG 9340T > C and FGA 2224G > A polymorphisms and plasma fibrinogen concentration. An elevated plasma fibrinogen gamma' concentration proved to be an independent predictor of MI [adjusted odds ratio (OR) (95% CI): 1.24 (1.01, 1.52)]. The plasma fibrinogen gamma' concentration was involved in a high-order interaction with total plasma fibrinogen and the FGG 9340T > C and FGA 2224G > A polymorphisms, associated with a further increased risk of MI [OR (95% CI): 3.22 (2.35, 4.39)].
Conclusions: Plasma fibrinogen gamma' concentration influences the risk of MI, and this relationship seems to be strengthened by the presence of an elevated total plasma fibrinogen concentration and the FGG 9340T and FGA 2224G alleles.
Xu X, Silveira A, Lundman P, Rahbar A, Soderberg-Naucler C Int J Cardiol Heart Vasc. 2024; 56:101570.
PMID: 39691830 PMC: 11650320. DOI: 10.1016/j.ijcha.2024.101570.
Proteomic Analysis of Serum Proteins from Patients with Severe Coronary Artery Calcification.
Zhang B, Kong X, Qiu G, Li L, Ma L Rev Cardiovasc Med. 2024; 23(7):229.
PMID: 39076904 PMC: 11266762. DOI: 10.31083/j.rcm2307229.
Pedersen N, Bladbjerg E, Juhl C, Larsen A, Munster A, de Maat M Res Pract Thromb Haemost. 2024; 8(1):102319.
PMID: 38379712 PMC: 10876905. DOI: 10.1016/j.rpth.2024.102319.
Levels of Fibrinogen Variants Are Altered in Severe COVID-19.
de Vries J, Visser C, van Ommen M, Rokx C, van Nood E, van Gorp E TH Open. 2023; 7(3):e217-e225.
PMID: 37501780 PMC: 10370639. DOI: 10.1055/a-2102-4521.
A mathematical model of fibrinogen-mediated erythrocyte-erythrocyte adhesion.
Lopes C, Curty J, Carvalho F, Hernandez-Machado A, Kinoshita K, Santos N Commun Biol. 2023; 6(1):192.
PMID: 36801914 PMC: 9938206. DOI: 10.1038/s42003-023-04560-4.